Back to 
GREENLIGHT CAPITAL INC
GREENLIGHT CAPITAL INCNENEUBASE THERAPEUTICS INC
Showing 0 of 16 quarters
Position history for GREENLIGHT CAPITAL INC's holdings in NEUBASE THERAPEUTICS INC
As of its Q1 2023 13F, Greenlight Capital held 2,727,027 shares of NEUBASE THERAPEUTICS, worth $504,500. Greenlight Capital's 13F filings listed NEUBASE THERAPEUTICS from Q3 2019 to Q1 2023, 15 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.